Universe Pharmaceuticals
UPC | NASDAQ
$1.48
-$0.03 (-1.99%)
At close: Nov 16, 2026, 4:00 PM ET
$1.45
-$0.03 (-2.03%)
After-hours:
Nov 16, 2026, 7:24 PM ET
Universe Pharmaceuticals Company Profile
Company profile explainedCompany Profile
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
Key Executives
| Name | Position |
|---|---|
| Gang Lai | Chief Executive Officer & Chairman |
| Baochang Liu | Chief Operating Officer |
| Lin Yang | Chief Financial Officer & Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 09, 2026 | EFFECT | Filing |
| Oct 06, 2026 | 6-K | Filing |
| Sep 29, 2026 | F-3 | Filing |
| Sep 03, 2026 | 6-K/A | [Amend] Filing |
| Sep 01, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 01, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 01, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 01, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 01, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Sep 01, 2026 | SC 13G | Statement of acquisition of beneficial ownership b... |
Universe Pharmaceuticals
| Country | China |
| IPO Date | Mar 23, 2021 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 216 |
| CEO | Gang Lai |
Contact Details
No. 265, Jingjiu Avenue Ji'An,
JX 343100 China
Stock Details
| Ticker Symbol | UPC |
| Exchange | NASDAQ |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| CIK Code | 0001809616 |
| CUSIP Number | G9442G138 |
| ISIN Number | KYG9442G1385 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove UPC